No.

Publication Date

Citing Article

1

2025

Johannes Klose, Jessica Doebereiner, Yoshiaki Sunami, Artur Rebelo, Ulrich Ronellenfitsch, Jorg Kleeff. Future of Pancreatic Cancer Therapy: Getting Better, But not Good Enough Ye, Archives of Medical Research. 2025; 56: 103336103336.  https://doi.org/10.1016/j.arcmed.2025.103336

2

2026

Nitin Kumar Singh, Firoz Ahmad, Adil Husain. Molecular dissection of pancreatic cancer signaling: Toward targeted therapies for KRAS, MDM2–TP53, EGFR, and PI3K/AKT/mTOR, Pathology - Research and Practice. 2026; 283: 156506156506.  https://doi.org/10.1016/j.prp.2026.156506

3

2026

Christina Parassiadis, Steven A Johnsen. Epigenetic and transcriptional control of classical and basal-like cell states in pancreatic ductal adenocarcinoma, Gastroenterology Report. 2026; 14: goag028.  https://doi.org/10.1093/gastro/goag028

4

2025

Valeria Tonini, Manuel Zanni. Pancreatic cancer in 2025: Have we found a solution?, World Journal of Gastroenterology. 2025; 31:   https://doi.org/10.3748/wjg.v31.i43.111433

5

2026

Teodorikez‐Wilfox Jimenez‐Rodriguez, Luljeta Ahmetaj, Teresa Alfaya Arias, Elisa Boni, Lali Bugadze, Jitesh Chauhan, Leticia De Las Vecillas, Denisa Ferastraoaru, Elena Izquierdo, Sophia N. Karagiannis, Francesca Levi‐Schaffer, Francesca Norelli, Emilio Nuñez‐Borque, Mariona Pascal, Aurélie Poli, Martina Vachová, Arantza Vega Castro, Marco Zurlo, Christine Breynaert. Melittin in AllergoOncology: From Honey Bee Venom to Anti‐Cancer Therapeutic Innovation—An EAACI Position Paper, Allergy. 2026; all.70421.  https://doi.org/10.1111/all.70421

6

2026

Maedeh Shahrabi, Asma Aliparast, Fatemeh Moosavi, Amirsajad Jafari, Negar Firouzabadi, Omidreza Firuzi. Sertraline Has Anticancer Effects and Enhances the Cytotoxicity of Chemotherapeutic Agents Against Pancreatic Cancer Cells, Archiv der Pharmazie. 2026; 359: e70290.  https://doi.org/10.1002/ardp.70290

7

2025

Dasari Sahithi, Asfi Rizwan, Garima Gupta, Umme Hani, Nazima Haider, Khang Wen Goh, Prashant Kesharwani. Engineering PEGylated dendrimers for targeted Cancer nanomedicine: From molecular design to therapeutic application, Microchemical Journal. 2025; 219: 115843115843.  https://doi.org/10.1016/j.microc.2025.115843

8

2026

Sam Banks, Belinda Lee, Nadia Ayres, Silja Schrader, Benjamin Thomson, Benjamin P. T. Loveday, Michael Michael, Frances Barnett, Sue‐Anne McLachlan, Brett Knowles, Mehrdad Nikfarjam, Jon Emery, Peter Gibbs. Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pathways Targets, ANZ Journal of Surgery. 2026; ans.70705.  https://doi.org/10.1111/ans.70705

9

2026

Fathima Zahraa Ozeer, Jemila Caplan Kester. Can Complex 3D Models Effectively Replace 2D and Animal Models to Investigate the Microbe-Tumor-Immune Axis in Pancreatic Cancer Studies?, Nutrients. 2026; 18: 2113.  https://doi.org/10.3390/nu18132113